LOGIN  |  HOME
Company Profile Report Comparative Business Report Sales Analysis Report Price Analysis Report Earnings Analysis Report
Wright Reports > Price Analysis Report > A > Adventrx Pharmaceuticals, Inc.

Adventrx Pharmaceuticals, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Adventrx Pharmaceuticals, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Adventrx Pharmaceuticals, Inc.. The Group's principal activity is focusing on in-licensing, developing and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates, ANX-530 and ANX-514, are novel emulsion formulations of currently marketed chemotherapy drugs. The Group is in development stage.

Not the Report you are looking for? Click here for more browsing options.

add Premium Analyses Reports:
Purchase Reports: (Combined total)
ALL Basic Reports on this Company $39.95 + Analyses Reports $64.95
Single Price Analysis Report $24.95    
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription $59.99 + Analyses Reports $89.99
Annual Basic Subscription $600/yr + Analyses Reports $750/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

PDF image view sample Single Report PDF image view sample All Basic Reports

Layout and Content of a Typical Report
Company Search:
Company Name
Ticker Symbol
Key Word Search:

Search Tips



HOME | ABOUT US | FEEDBACK | HELP | CONTENT MAP
Terms and Conditions

Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved. Powered by Manta